perrigo.com - PRGO Company profit before taxes, interest and amortization
Plants in Mexico, Ireland, and the US provided the launchpad for expansion, resulting in a peak in the distribution of EBITDA across periods for Perrigo Company plc (PRGO). Revenues are based on the mass production of vitamins and OTC products. Dominance in the pharmacy private label segment allows the company to displace expensive brands. The current 612.03 determines the magnitude of the absolute operating profit metric in monetary terms.
Summary analytical data breakdowns for Perrigo (PRGO)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Perrigo Company plc|PRGO - Long-Term Debt to Equity|Current Liabilities to Equity Perrigo Company PLC|PRGO - Company Aggregate Debts|Debts to Book Value Perrigo|PRGO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Perrigo|Intermediate Coverage Ratio perrigo.com
- earnings and market ratios statistics:
PRGO - Net Profit|Company Profit Forecast Perrigo Company plc|PRGO - P/E Multiple|Forward Price to Earnings Multiple perrigo.com|PRGO - Price/Earnings to Growth Ratio|Company Value to EBITDA Perrigo|PRGO - Operating profit before deduction of amortization|Earnings per share for the trailing year Perrigo|PRGO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months perrigo.com|PRGO - Earnings per share growth in current year|Expected net earnings per share growth next year Perrigo Company plc
Summary company analytics:Perrigo Company plc
The absolute EBITDA dynamics of Perrigo Company plc (PRGO) allow for the real-time tracking of the efficiency of the transition to high-margin health products and the results of logistics optimization. This indicator captures the daily cash inflow from core commercial activities, eliminating reporting lags and demonstrating the business's fundamental ability to act as a cash generator regardless of market volatility.
Competitors of Perrigo Company plc (PRGO)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Alvotech Biopharmaceuticals ALVO|Profit before payment of interest, taxes and amortization Liquidia Corporation (LQDA)|GLPG (glpg.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ANI Pharmaceuticals, Inc. ANIP|MNKD (MannKind Corp) - Profit before deduction of interest, taxes, depreciation and amortization|Amphastar - Operating profit EBITDA|Profit before interest, taxes and amortization Pacira Corp|ARS Pharmaceuticals (SPRY) - Profit before payment of interest, taxes and amortization|theravance.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Aquestive Therapeutics, Inc.|SCPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA TECX|Operating income before deduction of amortization Tonix Pharmaceuticals Holding|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Operating profit before depreciation charges Eupraxia Pharmaceuticals, Inc.|BHST - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Invizyne Technologies|ORMP (oramed.com) - Operating profit before deduction of amortization|Entera Bio - Income before deduction of interest, taxes and amortization|HYFT (MindWalk Holdings) - Operating profit EBITDA|Operating profit before deduction of amortization abvcpharma.com (ABVC)|Profit before payment of interest, taxes and amortization Cumberland Pharmaceuticals Inc. (CPIX)|QNTM - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization FibroGen Corp FGEN|TELO - Operating profit before deduction of amortization|RANI - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization SNYR|RLYB: Operating profit EBITDA|Lexaria Bioscience Corp. (LEXX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Pulmatrix Corp|Operating profit before amortization PTHL (Pheton)|Operating profit before deduction of amortization APM (Aptorum Group Limited)|LYRA - Profit before interest, taxes and amortization|Impact BioMedical - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TNFA|YCBD - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization PRFX|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|LIPO (lipella.com) - Profit before payment of interest, taxes and amortization|OPTN (OptiNose) - Operating profit EBITDA|Operating profit before deduction of amortization Pieris Pharmaceuticals Inc (PIRS)|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|PTPI: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Qilian International QLI|Income before deduction of interest, taxes and amortization SLRN|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
